The mission of Pulmonox Medical Corp, Critical Care, and Sleep Medicine is to deliver compassionate and effective patient care, to perform cutting-edge and innovative clinical, translational and basic science research, and to provide rigorous training of future leaders in academic Pulmonary, Critical Care and Sleep Medicine and Science. We aim to fulfill this mission in the best atmosphere possible – with a focus on work life balance, equity, community and engagement..
Reducing Hyperinflation, an Underlying Cause of Breathlessness
The majority of patients with advanced COPD/emphysema are treated with inhalers, medications and pulmonary rehabilitation. However, none of these treatments address the root cause of dyspnea – hyperinflation of the lungs. Thus, many patients – even stable patients – still experience significant breathlessness. And this, in turn, can result in the downward cycle of less activity, compromised quality of life, and increased dyspnea.
Zephyr Valve treatment leads to improved health status. Patients treated with Zephyr Valves experienced clinical benefits and improved quality of life when compared to patients who were on medications alone.1